You Position: Home > Paper
Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma
( views:144, downloads:0 )
- Author:
- No author available
- Journal Title:
- Chinese Medical Journal
- Issue:
- 12
- DOI:
- 10.3760/cma.j.issn.0366-6999.2012.12.027
- Key Word:
- sunitinib;targeted therapy;anti-angiogenesis;malignant pheochromocytoma
Abstract： Sporadic malignant pheochromocytoma,a rare disease with poor prognosis,is always difficult to treat due in part to lack of effective agents.We presented three patients with advanced malignant pheochromocytoma treated by sunitinib,which indicates that sunitinib is an effective agent for this malignancy.
- [1]LI Xue-song,WU Xiang,ZHAO Peng-ju,etc.Efficacy and safety of sunitinib in the treatment of metastatic renal cell carcinoma[J].2011,(18).
- [2]Adler JT,Sippel RS,Meyer-Rochow GY,etc.Pheochromocytoma: current approaches and future directions.[J].2008,13(7).
- [3]M, Nakane,S, Takahashi,I, Sekine,etc.Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline.[J].2003,14.
- [4]Eisenhofer G,Fojo T,Bachenheimer L,etc.Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma.[J].2001,93(8).
- [5]K C, Loh,P A, Fitzgerald,K K, Matthay,etc.The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients.[J].1997,20.
- [6]Manger WM,Eisenhofer G.Pheochromocytoma: diagnosis and management update.[J].2004,6(6).
- [7]Zhao JP,Rui WB,Shen ZJ,etc.Heparanase-1 and Cyclooxygenase-2: prognostic indicators of malignancy in pheochromocytomas.[J].2010,38(1).
- [8]Wanders J,Kaplan RS,Eisenhauer EA,etc.New guidelines to evaluate the response to treatment in solid tumors (see comments)[J].2000,92(3).
- [9]Lehnert H,Scholz T,Eisenhofer G,etc.Clinical review: Current treatment of malignant pheochromocytoma.[J].2007,92(4).
- [10]Bornstein SR,Shulkin BL,Greene LA,etc.Malignant pheochromocytoma: current status and initiatives for future progress.[J].2004,11(3).
- [11]H C, Klingler,P J, Klingler,J K, Martin,etc.Pheochromocytoma.[J].2001,57(6).
- [12]NAZANENE H. ESFANDIARI,JAMES C. SISSON,BARRY L. SHULKIN.Courses of Malignant Pheochromocytoma: Implications for Therapy[J].2006,1073(aug).
- [13]Joshua AM,Evans A,Freeman M,etc.Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.[J].2009,94(1).
- [14]Chow LQ,Eckhardt SG.Sunitinib: from rational design to clinical efficacy.[J].2007,25(7).